Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Operating Expenses (2020 - 2025)

Celularity has reported Operating Expenses over the past 6 years, most recently at $18.2 million for Q3 2025.

  • Quarterly results put Operating Expenses at $18.2 million for Q3 2025, down 12.67% from a year ago — trailing twelve months through Sep 2025 was $89.1 million (up 39.31% YoY), and the annual figure for FY2024 was $92.6 million, down 56.95%.
  • Operating Expenses for Q3 2025 was $18.2 million at Celularity, down from $21.6 million in the prior quarter.
  • Over the last five years, Operating Expenses for CELU hit a ceiling of $103.0 million in Q3 2023 and a floor of -$13.4 million in Q4 2022.
  • Median Operating Expenses over the past 5 years was $21.9 million (2025), compared with a mean of $28.6 million.
  • Biggest five-year swings in Operating Expenses: surged 30542.6% in 2021 and later tumbled 167.43% in 2022.
  • Celularity's Operating Expenses stood at $19.8 million in 2021, then tumbled by 167.43% to -$13.4 million in 2022, then surged by 90.99% to -$1.2 million in 2023, then soared by 2378.64% to $27.4 million in 2024, then crashed by 33.66% to $18.2 million in 2025.
  • The last three reported values for Operating Expenses were $18.2 million (Q3 2025), $21.6 million (Q2 2025), and $21.9 million (Q1 2025) per Business Quant data.